Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
blueprint medicines
boston blog main
boston top stories
cancer
2
×
indiana blog main
indiana top stories
life sciences
national blog main
national top stories
roche
san francisco blog main
2
×
san francisco top stories
avapritinib
biotech
boston
boulder/denver blog main
boulder/denver top stories
cancer drugs
capmatinib
clinical trials
companion diagnostic
detroit blog main
detroit top stories
dna sequencing
drugs
eli lilly
entrectinib
europe blog main
europe top stories
express scripts
fda
foundation medicine
gastrointestinal stromal tumors
genentech
josh bilenker
keytruda
larotrectinib
life science
loxo oncology
medullary thyroid cancer
What
cancer
drug
2
×
fda
genetic
2
×
address
approval
approved
approves
blueprint
carries
certain
deeper
designed
dna
fingerprint
going
latest
matter
medicine
medicines
nd
new
oks
pass
ret
second
signature
signatures
targeted
targeting
targets
therapy
time
tissues
tumor's
world
Language
unset
Current search:
xconomy.com
×
cancer
×
" san francisco blog main "
×
genetic
×
drug
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues